Start Date
Immediate
Expiry Date
22 Nov, 25
Salary
219400.0
Posted On
23 Aug, 25
Experience
0 year(s) or above
Remote Job
Yes
Telecommute
Yes
Sponsor Visa
No
Skills
Regulatory Requirements, Risk Assessment, Technical Reports, Process Validation, Manufacturing, Cmos, Project Management Skills, Design
Industry
Pharmaceuticals
Corcept is leading the way in the research and development of cortisol modulators, molecules that regulate cortisol activity at the glucocorticoid receptor (GR). To date, we have discovered more than 1,000 selective proprietary cortisol modulators.
In 2012, we received FDA approval of Korlym® (mifepristone), the first approved treatment for hypercortisolism (Cushing’s syndrome).
Today, our team and collaborators continue to unlock the possibilities of cortisol modulation as a way to treat serious diseases. With more than 30 ongoing studies across a wide range of disease areas, including endocrinology, oncology, metabolism, and neurology, we remain dedicated to advancing the possibilities of cortisol modulation.
What began as a ripple of scientific truth is now poised to unleash a sea change of discovery representing a fundamental shift in the way we understand and treat disease.
This position will manage contract development and manufacturing organizations (CDMOs) that produce small molecule Active Pharmaceutical Ingredients (API) in support of CTM and commercial supply. Responsibilities include managing CDMO business relationship, overseeing development and production activities of small molecule APIs at CDMOs, and providing technical support and troubleshooting, as well as authoring NDA/MAA.
PREFERRED SKILLS, QUALIFICATIONS AND TECHNICAL PROFICIENCIES:
PREFERRED EDUCATION AND EXPERIENCE: